-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on CalciMedica, Maintains $16 Price Target

Benzinga·03/04/2025 13:18:57
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $16 price target.